Methods of treating recurrent ovarian cancer and endometrial cancer with bispecific anti-muc16 x anti-cd28 antibodies in combination with anti-pd-1 antibodies or bispecific anti-muc16 x anti-cd3 antibodies
IL328613APending Publication Date: 2026-07-01REGENERON PHARMACEUTICALS INC +3
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- IL · IL
- Patent Type
- Applications
- Current Assignee / Owner
- REGENERON PHARMACEUTICALS INC
- Filing Date
- 2026-05-24
- Publication Date
- 2026-07-01
Need to check novelty before this filing date? Find Prior Art
No text content released.